Axogen Inc (AXGN)
12.64
+0.17
(+1.36%)
USD |
NASDAQ |
Nov 15, 16:00
12.67
+0.03
(+0.24%)
After-Hours: 20:00
Axogen Research and Development Expense (TTM): 29.23M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 29.23M |
| June 30, 2024 | 28.93M |
| March 31, 2024 | 29.42M |
| December 31, 2023 | 28.33M |
| September 30, 2023 | 26.98M |
| June 30, 2023 | 27.33M |
| March 31, 2023 | 27.21M |
| December 31, 2022 | 27.16M |
| September 30, 2022 | 26.65M |
| June 30, 2022 | 26.00M |
| March 31, 2022 | 24.70M |
| December 31, 2021 | 24.18M |
| September 30, 2021 | 22.81M |
| June 30, 2021 | 20.63M |
| March 31, 2021 | 18.98M |
| December 31, 2020 | 17.85M |
| September 30, 2020 | 17.83M |
| June 30, 2020 | 17.78M |
| March 31, 2020 | 17.99M |
| December 31, 2019 | 17.51M |
| September 30, 2019 | 16.41M |
| June 30, 2019 | 15.53M |
| March 31, 2019 | 13.85M |
| December 31, 2018 | 11.77M |
| September 30, 2018 | 9.937M |
| Date | Value |
|---|---|
| June 30, 2018 | 8.426M |
| March 31, 2018 | 7.346M |
| December 31, 2017 | 6.699M |
| September 30, 2017 | 5.906M |
| June 30, 2017 | 5.229M |
| March 31, 2017 | 4.645M |
| December 31, 2016 | 4.212M |
| September 30, 2016 | 3.927M |
| June 30, 2016 | 3.745M |
| March 31, 2016 | 3.544M |
| December 31, 2015 | 3.237M |
| September 30, 2015 | 3.327M |
| June 30, 2015 | 3.072M |
| March 31, 2015 | 2.892M |
| December 31, 2014 | 3.033M |
| September 30, 2014 | 2.676M |
| June 30, 2014 | 2.589M |
| March 31, 2014 | 2.531M |
| December 31, 2013 | 2.126M |
| September 30, 2013 | 1.872M |
| June 30, 2013 | 1.669M |
| March 31, 2013 | 1.538M |
| December 31, 2012 | 1.427M |
| September 30, 2012 | 1.315M |
| June 30, 2012 | 1.154M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
17.51M
Minimum
Dec 2019
29.42M
Maximum
Mar 2024
23.87M
Average
25.35M
Median
Research and Development Expense (TTM) Benchmarks
| Cutera Inc | 18.38M |
| IRIDEX Corp | 6.272M |
| Stereotaxis Inc | 9.182M |
| Electromed Inc | 0.656M |
| Myomo Inc | 4.090M |